regulation, microbiology
Self-prescribing Patients?
Jef Akst | Mar 13, 2012
The FDA considers making some drugs for diabetes, asthma, and other ailments available over the counter.
Contributors
The Scientist Staff | Mar 1, 2012
Meet some of the people featured in the March 2012 issue of The Scientist.
Biota Babble
Edyta Zielinska | Mar 1, 2012
Editor's choice in immunology
TB Screen Glows Green
Sabrina Richards | Feb 13, 2012
Infection by GFP-encoding viruses enables quick, easy detection of tuberculosis in patient samples.
C. diff Infection Source Unclear
Sabrina Richards | Feb 7, 2012
Only a quarter of Clostridium difficile infections in one hospital system were traced to contact with a symptomatic patient.
Opinion: No Objections to Nano?
Susanna Priest | Feb 3, 2012
While biotechnology has met with mixed public reactions, to date nanotechnology seems to invoke much less public concern.
A Bill to Expedite Drug Production
Jef Akst | Feb 2, 2012
Legislation proposes speeding certain drug applications submitted to the US Food and Drug Administration.
Federal Biosecurity Panel Speaks
Bob Grant | Feb 1, 2012
The US National Science Advisory Board for Biosecurity explains why it recommended redacting the details of studies reporting on a highly transmissible H5N1 strain.
Opinion: Celebrities Pushing Drugs?
Howard Brody | Jan 30, 2012
Celebrity spokespeople for pharma companies can manipulate the public’s understanding of disease.
Arsenic-based Life Challenged Again
Hannah Waters | Jan 24, 2012
An attempt to regrow the infamous GFAJ-1 bacteria, reported to incorporate arsenic into its DNA backbone, has failed.